Sergio Valdés
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Sergio Valdés has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Gemma Rojo-Martínez
Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, 28029 Madrid, Spain
3 shared publications - Elías Delgado
Department of Endocrinology and Nutrition, Central University Hospital of Asturias, Health Research Institute of the Principality of Asturias (ISPA), University of Oviedo, 33033 Oviedo, Spain
2 shared publications - Federico Soriguer
Departamento de Endocrinología and Nutrición, Hospital Regional Universitario de Málaga, Instituto de Investigación Biomédica de Málaga (IBIMA), 29009 Málaga, Spain
2 shared publications - María Soledad Ruiz de Adana
Diabetes Unit, Endocrinology and Nutrition Service, Regional University Hospital of Málaga, IBIMA/BIONAD, Ciberdem, 29010 Malaga, Spain
2 shared publications Patricia Botas
2 shared publicationsAlberto Machado
1 shared publication
Latest Publications
- 1 March 2012
- Published by Elsevier in Avances en Diabetología
- Vol. 28 (2) , 35-37
El estudio Di@bet.es, ¿y ahora qué?
- 1 March 2012
- Published by Elsevier in Avances en Diabetología
- Vol. 28 (2) , 35-37
El estudio Di@bet.es, ¿y ahora qué?
- 12 September 2011
- Published by American Psychological Association (APA)
Fear of Hypoglycemia Scale
- 23 April 2011
- Published by Elsevier in Medicina Clinica
- Vol. 136 (11) , 465-470
La hemoglobina glucosilada como marcador de riesgo de hiperuricemia en la población general
- 23 April 2011
- Published by Elsevier in Medicina Clinica
- Vol. 136 (11) , 465-470
La hemoglobina glucosilada como marcador de riesgo de hiperuricemia en la población general
- 1 March 2008
- Published by Elsevier in Metabolism
- Vol. 57 (3) , 399-403
Does the new American Diabetes Association definition for impaired fasting glucose improve its ability to predict type 2 diabetes mellitus in Spanish persons? The Asturias Study
- 1 March 2008
- Published by Elsevier in Metabolism
- Vol. 57 (3) , 399-403
Does the new American Diabetes Association definition for impaired fasting glucose improve its ability to predict type 2 diabetes mellitus in Spanish persons? The Asturias Study
- 1 September 2007
- Published by Elsevier in Medicina Clinica
- Vol. 129 (9) , 352-355
Evolución de la prevalencia de la diabetes tipo 2 en población adulta española
- 1 September 2007
- Published by Elsevier in Medicina Clinica
- Vol. 129 (9) , 352-355
Evolución de la prevalencia de la diabetes tipo 2 en población adulta española
- 1 September 2007
- Published by American Diabetes Association in Diabetes Care
- Vol. 30 (9) , 2258-2263
Population-Based Incidence of Type 2 Diabetes in Northern Spain
OBJECTIVE—The aim of this study was to define the incidence of type 2 diabetes in a low-risk Caucasian population in northern Spain and its association with various risk factors. RESEARCH DESIGN AND METHODS—The Asturias Study is a prospective, population-based survey of diabetes and cardiovascular risk factors. The baseline examination was carried out during 1998–1999 when 1,034 individuals, aged 30–75 years, were randomly selected to determine the prevalence of type 2 diabetes and pre-diabetes in the Principality of Asturias (northern Spain). In 2004–2005, these same subjects were invited for a follow-up examination; 700 participated. This study includes only those individuals who did not have diabetes at baseline. We used the World Health Organization 1999 criteria to classify glucose metabolism at both baseline and follow-up. RESULTS—The incidence of diabetes adjusted for the age and sex structure of Asturias was 10.8 cases/1,000 person-years (95% CI 8.1–14.8). The incidence rates were 5 cases/1,000 person-years in individuals with normoglycemia, 21 cases/1,000 person-years in individuals with isolated impaired glucose tolerance (IGT), 34.7 cases/1,000 person-years in individuals with isolated impaired fasting glucose (IFG), and 95.2 cases/1,000 person-years in individuals with combined IFG-IGT. Stepwise multiple logistic regression analysis showed that, together with fasting plasma glucose (FPG) and 2-h plasma glucose, which were the strongest predictors of diabetes, triglycerides and BMI were also independently associated with progression to diabetes. CONCLUSIONS—In this 6-year prospective population-based study, we found an incidence of type 2 diabetes of 10.8 cases/1,000 person-years. Both FPG and 2-h plasma glucose were strongly predictive of diabetes, and their effect was additive.
- 1 September 2007
- Published by American Diabetes Association in Diabetes Care
- Vol. 30 (9) , 2258-2263
Population-Based Incidence of Type 2 Diabetes in Northern Spain
OBJECTIVE—The aim of this study was to define the incidence of type 2 diabetes in a low-risk Caucasian population in northern Spain and its association with various risk factors. RESEARCH DESIGN AND METHODS—The Asturias Study is a prospective, population-based survey of diabetes and cardiovascular risk factors. The baseline examination was carried out during 1998–1999 when 1,034 individuals, aged 30–75 years, were randomly selected to determine the prevalence of type 2 diabetes and pre-diabetes in the Principality of Asturias (northern Spain). In 2004–2005, these same subjects were invited for a follow-up examination; 700 participated. This study includes only those individuals who did not have diabetes at baseline. We used the World Health Organization 1999 criteria to classify glucose metabolism at both baseline and follow-up. RESULTS—The incidence of diabetes adjusted for the age and sex structure of Asturias was 10.8 cases/1,000 person-years (95% CI 8.1–14.8). The incidence rates were 5 cases/1,000 person-years in individuals with normoglycemia, 21 cases/1,000 person-years in individuals with isolated impaired glucose tolerance (IGT), 34.7 cases/1,000 person-years in individuals with isolated impaired fasting glucose (IFG), and 95.2 cases/1,000 person-years in individuals with combined IFG-IGT. Stepwise multiple logistic regression analysis showed that, together with fasting plasma glucose (FPG) and 2-h plasma glucose, which were the strongest predictors of diabetes, triglycerides and BMI were also independently associated with progression to diabetes. CONCLUSIONS—In this 6-year prospective population-based study, we found an incidence of type 2 diabetes of 10.8 cases/1,000 person-years. Both FPG and 2-h plasma glucose were strongly predictive of diabetes, and their effect was additive.